PCRX - Pacira Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

PCRX is currently covered by 11 analysts with an average price target of $39.75. This is a potential upside of $12.88 (47.93%) from yesterday's end of day stock price of $26.87.

Pacira Pharmaceuticals's activity chart (see below) currently has 228 price targets and 218 ratings on display. The stock rating distribution of PCRX is 91.67% BUY and 8.33% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 69.49% with an average time for these price targets to be met of 330.08 days.

Highest price target for PCRX is $57, Lowest price target is $42, average price target is $39.75.

Most recent stock forecast was given by CHRISTOPHER NEYOR from JPMORGAN on 07-Mar-2024. First documented stock forecast 18-Jan-2013.

Currently out of the existing stock ratings of PCRX, 33 are a BUY (91.67%), 3 are a HOLD (8.33%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

45

$16.52 (58.01%)

83

1 months 12 days ago

1/3 (33.33%)

$14.36 (46.87%)

239

Buy

57

$28.52 (100.14%)

57

1 months 15 days ago

13/23 (56.52%)

$27.8 (95.21%)

233

Buy

45

$16.52 (58.01%)

45

1 months 18 days ago

2/12 (16.67%)

$16.14 (55.93%)

878

Buy

45

$16.52 (58.01%)

58

1 months 18 days ago

0/5 (0%)

$16.14 (55.93%)

Buy

57

$28.52 (100.14%)

60

2 months 11 days ago

0/2 (0%)

$29.3 (105.78%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is PCRX (Pacira Pharmaceuticals) average time for price targets to be met?

On average it took 330.08 days on average for the stock forecasts to be realized with a an average price target met ratio 69.49

Which analyst has the current highest performing score on PCRX (Pacira Pharmaceuticals) with a proven track record?

LIANA MOUSSATOS

Which analyst has the most public recommendations on PCRX (Pacira Pharmaceuticals)?

Liana Moussatos works at WEDBUSH and has 5 price targets and 7 ratings on PCRX

Which analyst is the currently most bullish on PCRX (Pacira Pharmaceuticals)?

Liana Moussatos with highest potential upside - $65.52

Which analyst is the currently most reserved on PCRX (Pacira Pharmaceuticals)?

Irina Koffler with lowest potential downside - -$11.69

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?